Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization
2022 Sep 16; 25(9):104925.
http://www.ncbi.nlm.nih.gov/pubmed/35992305
https://connects.catalyst.harvard.edu/Profiles/profile/203375324